跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABIRATERONE-DRLA abiraterone acetate 250 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ABIRATERONE-DRLA abiraterone acetate 250 mg tablet bottle
Approved
STANDARD
ABIRATERONE-DRLA abiraterone acetate 250 mg tablet bottle
Dr Reddys Laboratories Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
05bd53d40580345d
Company
Dr Reddys Laboratories Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
05bd53d40580345d
Product Name
ABIRATERONE-DRLA abiraterone acetate 250 mg tablet bottle
Artg Id
286571
Artg Name
ABIRATERONE-DRLA abiraterone acetate 250 mg tablet bottle
Sponsor
Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path
/organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date
2024-11-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
05bd53d40580345d
Type
Standard
Back to TGA Approvals
